Source:http://linkedlifedata.com/resource/pubmed/id/15771858
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-3-17
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0210-5705
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
126-34
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
[GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease].
|
pubmed:affiliation |
Servicio de Aparato Digestivo, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Review,
Practice Guideline
|